author-photo

Gianluca Schiavoni

University of Perugia

23

Papers

1318

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (2)
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (4)
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.

2020 Modern Pathology
Show All
- Source
- Cite
- Save
Citations (13)
EBV LEAVES ITS MARK: NEW EVIDENCE OF > HYPOTHESIS IN B-CELL LYMPHOMAS FROM NON-CONVENTIONAL METHODS

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML

2018 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (29)
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma

2018 Blood
Show All
- Source
- Cite
- Save
Citations (79)
Genomics of Hairy Cell Leukemia

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (36)
New Recurrently Mutated Genes in Classical Hodgkin Lymphoma Revealed By Whole-Exome Sequencing of Microdissected Tumor Cells

2016 Blood
Show All
- Source
- Cite
- Save
Citations (7)
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity

2015 Blood
Show All
- Source
- Cite
- Save
Citations (58)
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia

2014
Show All
- Source
- Cite
- Save
Citations (0)